Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics

Memo

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.At the conclusion of this course, participants will be able to:• Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT• Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice• Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging• Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT URLs:Tickets: https://go.evvnt.com/1875091-2?pid=5569 Virtual: https://go.evvnt.com/1875091-3?pid=5569  Date and Time: On Thu, 09 May 2024 07:30 - Fri, 10 May 2024 16:45 Venue details: Wynn Las Vegas, 3131 Las Vegas Boulevard South, Las Vegas, Nevada, 89109, United States Prices:Practicing Physician/Industry: USD 1395.00,Military/Retired/Scientist/VA: USD 1295.00,PA/Nurse: USD 1195.00,Resident*/Fellow*: USD 1095.00,Technologist: USD 995.00 Speakers: Phillip Kuo, MD, PhD, FACR, Andrew Quon, MD, Don Yoo, MD